Aterian, Inc.

NASDAQ:ATER

3.24 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 27.98420.21432.75439.66835.26434.87954.90266.32658.26841.67363.32268.12168.18848.13641.49258.78359.825.62825.63440.60330.36817.84619.70324.67214.58814.316
Cost of Revenue 11.0937.04616.04520.08520.36815.78234.53436.13526.91718.06634.4433.94635.44522.07322.7430.68832.215.3316.55223.07618.60811.17511.37714.26210.80810.849
Gross Profit 16.89113.16816.70919.58314.89619.09720.36830.19131.35123.60728.88234.17532.74326.06318.75228.09527.610.2989.08217.52711.766.6718.32610.413.783.467
Gross Profit Ratio 0.6040.6510.510.4940.4220.5480.3710.4550.5380.5660.4560.5020.480.5410.4520.4780.4620.4020.3540.4320.3870.3740.4230.4220.2590.242
Reseach & Development Expenses 000.8080.8521.7091.2471.431.7061.731.1442.6222.7672.3242.1241.5511.8462.4512.2812.4762.6341.861.1630.8450.790.8971.123
General & Administrative Expenses 4.9345.2323.6544.3266.2815.9598.75810.3699.5719.54111.9910.8439.9910.9767.0787.1998.3528.0038.0037.9994.4143.3663.1872.7673.132.206
Selling & Marketing Expenses 15.16213.21420.20720.92120.55720.22632.50733.79231.86622.97430.65332.33739.3125.06916.53318.94418.61813.9113.61617.30711.8289.27411.95111.568.1638.793
SG&A 20.09618.44623.8614.32626.83826.18541.26544.16141.43732.51542.64343.1849.336.04523.61126.14326.9721.91321.61925.30616.24212.6415.13814.32711.29310.999
Other Expenses -0.0436.168-0.1590.836-0.176-0.0540.083-12.663.258-5.81-0.002-0.005-0.005-0.0330.0230.0230.006-0.0250.012-0.0210.013-0.045-0.0310.019-0.0160.042
Operating Expenses 20.09618.44624.6696.01428.54727.43242.69545.86743.16733.65945.26545.94751.62438.16925.16227.98929.42124.19424.09527.9418.10213.80315.98315.11712.1912.122
Operating Income -3.205-5.278-7.9613.569-36.436-8.335-22.327-15.676-10.125-10.052-1.967-7.5274.468-27.751-19.1410.106-1.821-13.896-15.013-10.413-6.342-7.132-7.657-4.707-8.41-8.655
Operating Income Ratio -0.115-0.261-0.2430.342-1.033-0.239-0.407-0.236-0.174-0.241-0.031-0.110.066-0.577-0.4610.002-0.03-0.542-0.586-0.256-0.209-0.4-0.389-0.191-0.577-0.605
Total Other Income Expenses Net -0.2190.187-0.756-19.749-20.764-17.4391.89-101.301-4.323-32.72412.318-95.977-12.709-66.027-36.1010.0230.006-0.0250.012-0.0210.013-0.045-0.0310.019-0.0160.042
Income Before Tax -3.424-5.091-8.716-6.18-34.761-25.774-20.437-116.977-16.477-42.776-4.839-110.535-36.265-82.553-44.352-0.805-2.892-15.03-16.019-11.309-7.61-8.389-8.538-5.127-8.932-9.171
Income Before Tax Ratio -0.122-0.252-0.266-0.156-0.986-0.739-0.372-1.764-0.283-1.026-0.076-1.623-0.532-1.715-1.069-0.014-0.048-0.586-0.625-0.279-0.251-0.47-0.433-0.208-0.612-0.641
Income Tax Expense 0.2050.071-1.0090.090.0260.026-0.133-0.075-0.16832.7240.470.0210.0414.3870.0020.9830.0451.1080.0060.0080.0151.1680.0520.4580.0030.601
Net Income -3.629-5.162-7.707-6.27-34.787-25.8-20.304-116.902-16.309-75.5-5.309-110.556-36.306-82.553-44.354-0.805-2.937-15.03-16.025-11.317-7.625-8.389-8.59-5.127-8.935-9.171
Net Income Ratio -0.13-0.255-0.235-0.158-0.986-0.74-0.37-1.763-0.28-1.812-0.084-1.623-0.532-1.715-1.069-0.014-0.049-0.586-0.625-0.279-0.251-0.47-0.436-0.208-0.612-0.641
EPS -0.52-0.063-1.17-0.95-5.38-4.03-3.21-1.81-0.26-1.37-0.11-3.13-1.23-3.15-2.12-0.047-0.19-0.99-1.06-0.75-0.62-0.49-0.49-0.29-0.51-0.52
EPS Diluted -0.52-0.063-1.17-0.95-5.38-4.03-3.21-1.81-0.26-1.37-0.11-3.13-1.23-3.15-2.12-0.047-0.19-0.99-1.06-0.75-0.62-0.49-0.49-0.29-0.51-0.52
EBITDA -2.775-4.85-7.49113.569-12.625-6.627-20.486-28.336-9.768-14.016-16.385-9.772-17.078-10.935-6.3870.255-1.77-13.856-15.001-10.313-6.329-7.121-7.622-4.628-8.365-8.545
EBITDA Ratio -0.099-0.24-0.2290.342-0.358-0.19-0.373-0.427-0.168-0.336-0.259-0.143-0.25-0.227-0.1540.004-0.03-0.541-0.585-0.254-0.208-0.399-0.387-0.188-0.573-0.597